Talecris Biotherapeutics Files for $1 Billion IPO

WASHINGTON, July 27 (Reuters) - Biopharmaceutical firm Talecris Biotherapeutics Holdings Corp. said on Friday it is planning a $1 billion initial public offering of common stock.

MORE ON THIS TOPIC